NO970607L - Anordning av selegilin i behandling av epileptiske tilstander - Google Patents

Anordning av selegilin i behandling av epileptiske tilstander

Info

Publication number
NO970607L
NO970607L NO970607A NO970607A NO970607L NO 970607 L NO970607 L NO 970607L NO 970607 A NO970607 A NO 970607A NO 970607 A NO970607 A NO 970607A NO 970607 L NO970607 L NO 970607L
Authority
NO
Norway
Prior art keywords
selegiline
pct
arrangement
treatment
epileptic conditions
Prior art date
Application number
NO970607A
Other languages
English (en)
Other versions
NO314684B1 (no
NO970607D0 (no
Inventor
Wolfgang Loescher
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of NO970607L publication Critical patent/NO970607L/no
Publication of NO970607D0 publication Critical patent/NO970607D0/no
Publication of NO314684B1 publication Critical patent/NO314684B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19970607A 1994-08-11 1997-02-10 Anvendelse av selegilin til fremstilling av farmasöytiske preparater for behandling av epileptiske tilstander NO314684B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428444A DE4428444A1 (de) 1994-08-11 1994-08-11 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
PCT/DE1995/000981 WO1996004897A1 (de) 1994-08-11 1995-07-27 Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Publications (3)

Publication Number Publication Date
NO970607L true NO970607L (no) 1997-02-10
NO970607D0 NO970607D0 (no) 1997-02-10
NO314684B1 NO314684B1 (no) 2003-05-05

Family

ID=6525440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970607A NO314684B1 (no) 1994-08-11 1997-02-10 Anvendelse av selegilin til fremstilling av farmasöytiske preparater for behandling av epileptiske tilstander

Country Status (23)

Country Link
US (1) US5952388A (no)
EP (1) EP0774961B1 (no)
JP (1) JP3922307B2 (no)
CN (1) CN1081918C (no)
AT (1) ATE239458T1 (no)
AU (1) AU691316B2 (no)
BR (1) BR9508531A (no)
CA (1) CA2197176C (no)
CZ (1) CZ285681B6 (no)
DE (2) DE4428444A1 (no)
DK (1) DK0774961T3 (no)
EE (1) EE04176B1 (no)
ES (1) ES2199252T3 (no)
HU (1) HU223529B1 (no)
MY (1) MY116362A (no)
NO (1) NO314684B1 (no)
PL (1) PL188040B1 (no)
PT (1) PT774961E (no)
RU (1) RU2155584C2 (no)
SK (1) SK283205B6 (no)
TR (1) TR199500984A2 (no)
TW (1) TW448044B (no)
WO (1) WO1996004897A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
EP1441708B1 (en) * 2001-11-05 2009-04-08 Krele Pharmaceuticals LLC Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
GB201715919D0 (en) * 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2107552C (en) * 1991-04-04 2001-08-28 William G. Tatton Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5648087A (en) * 1993-03-09 1997-07-15 Sanofi Sante Nutrition Animale Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition

Also Published As

Publication number Publication date
PL188040B1 (pl) 2004-11-30
JP3922307B2 (ja) 2007-05-30
EP0774961B1 (de) 2003-05-07
CN1081918C (zh) 2002-04-03
WO1996004897A1 (de) 1996-02-22
CA2197176A1 (en) 1996-02-22
US5952388A (en) 1999-09-14
CN1155241A (zh) 1997-07-23
TW448044B (en) 2001-08-01
MX9701031A (es) 1998-05-31
BR9508531A (pt) 1998-12-01
CZ285681B6 (cs) 1999-10-13
NO314684B1 (no) 2003-05-05
SK283205B6 (sk) 2003-03-04
TR199500984A2 (tr) 1996-06-21
HU223529B1 (hu) 2004-08-30
PL318292A1 (en) 1997-06-09
DE59510674D1 (de) 2003-06-12
CA2197176C (en) 2007-06-26
ES2199252T3 (es) 2004-02-16
EE9700068A (et) 1997-10-15
RU2155584C2 (ru) 2000-09-10
CZ40797A3 (en) 1997-07-16
DK0774961T3 (da) 2003-09-01
HUT77175A (hu) 1998-03-02
AU691316B2 (en) 1998-05-14
NO970607D0 (no) 1997-02-10
AU2976095A (en) 1996-03-07
MY116362A (en) 2004-01-31
DE4428444A1 (de) 1996-02-15
JPH10504029A (ja) 1998-04-14
ATE239458T1 (de) 2003-05-15
PT774961E (pt) 2003-09-30
EP0774961A1 (de) 1997-05-28
EE04176B1 (et) 2003-12-15
SK19997A3 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
FI963070A0 (fi) Klooripyrimidiinivälituotteita
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
SE9703693D0 (sv) Novel combination
DK0705099T3 (da) Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse
DE69827149D1 (de) Agmatin für die behandlung neuropathischer schmerzen
DE69400799T2 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
SE9701161D0 (sv) New use I
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
NO970607L (no) Anordning av selegilin i behandling av epileptiske tilstander
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
FI970434A (fi) Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
NO20005548D0 (no) Mykobakterieinhibitorer
SE9802538D0 (sv) New pharmaceutically active compounds
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
BR0206918A (pt) Uso de iloperidona
BR9909878A (pt) 10-canfosulfonato de paroxetina para tratamento de distúrbios do sistema nervoso central
SE9403861D0 (sv) Novel medicinal use
ES2093515T3 (es) Aplicacion del riluzol como radio-restaurador.
BR0211522A (pt) Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
EA200501053A1 (ru) Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы
RU94011030A (ru) Способ увеличения времени защитного действия легочно-автоматических дыхательных аппаратов
NO974687D0 (no) Kondenserte <beta>-carboliner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees